Home › Bladder Cancer › Illinois › Waukegan
Bladder Cancer clinical trials in Waukegan, IL
3 studies for Bladder Cancer are looking for participants at sites in and around Waukegan (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecruitingPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi away
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- City of Hope Cancer Center-Chicago, Zion · 6 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
Other studies in Waukegan
- Lung Cancer16 studies
- Non-Small Cell Lung Cancer16 studies
- Breast Cancer12 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Ulcerative Colitis7 studies
- Ovarian Cancer6 studies
- Metastatic Cancer6 studies
- Prostate Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Crohn's Disease5 studies
- Colorectal Cancer5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.